Last quarter (Q ), Cell Kinetics's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q, Cell Kinetics's net income was $3.16M. See Cell Kinetics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 08	Dec 07	Dec 06
Total Revenue	$ 472.90K	$ 486.56K	$ 15.06K	$ 21.00K	-	-
Cost of Revenue	$ 102.87K	$ -113.19K	$ 17.27K	$ 14.00K	-	-
Gross Profit	$ 372.64K	$ 373.36K	$ -2.21K	$ 7.00K	-	-
Operating Expense	$ 9.57M	$ 15.19M	$ 4.51M	$ 2.41M	$ 2.08M	$ 1.78M
Operating Income	$ -9.20M	$ -14.82M	$ -4.51M	$ -2.40M	$ -2.08M	$ -1.78M
Net Non Operating Interest Income Expense	$ -6.49K	$ -102.00	$ -508.00	$ 22.00K	-	-
Other Income Expense	$ -1.02M	$ -1.90M	$ -2.33M	-	-	-
Pretax Income	$ -15.63M	$ -13.94M	$ -2.17M	-	-	-
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -9.20M	$ -13.94M	$ -2.17M	$ -2.38M	$ -2.10M	$ -1.81M
Basic EPS	$ -0.49	$ -0.55	$ -0.21	$ -0.12	$ -0.13	$ -0.11
Diluted EPS	$ -0.54	$ -0.53	$ -0.21	$ -0.12	$ -0.13	$ -0.11
Basic Average Shares	$ 101.32M	$ 25.25M	$ 10.40M	$ 20.17M	$ 16.72M	$ 16.50M
Diluted Average Shares	$ 77.87M	$ 25.25M	$ 10.40M	$ 20.17M	$ 16.72M	$ 16.50M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 9.67M	$ 15.08M	$ 4.52M	$ 2.42M	$ 2.08M	$ 1.78M
Net Income From Continuing And Discontinued Operation	$ -15.90M	$ -13.94M	$ -2.17M	$ -2.38M	$ -2.10M	$ -1.81M
Normalized Income	-	-	-	$ -2.38M	$ -2.10M	$ -1.81M
Interest Expense	-	-	-	$ 2.00K	-	-
EBIT	$ -15.62M	$ -13.94M	$ -2.17M	$ -2.40M	$ -2.08M	$ -1.78M
EBITDA	$ -8.22M	$ -13.90M	$ -2.17M	$ -2.38M	$ -1.99M	$ -1.71M

Currency in USD

Cell Kinetics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing